Ticker
CARMCompany Name
CARISMA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQDate | Market Capitalization | Net Cash Flow - Issuance (Purchase) of Equity Shares | Net Cash Flow - Issuance (Repayment) of Debt Securities | Net Cash Flow - Dividends & Other Cash Distributions | Shareholder Yield |
---|---|---|---|---|---|
6/30/2025 | $ 11.49M | $ 111K | $ -1.82M | $ 0 | 14.85% |
3/31/2025 | $ 7.77M | $ 113K | $ -1.75M | $ 0 | 21.02% |
12/31/2024 | $ 12.95M | $ 2.4M | $ -2.05M | $ 0 | -2.66% |
9/30/2024 | $ 43M | $ 3.11M | $ -2.05M | $ 0 | -2.48% |
6/30/2024 | $ 37.43M | $ 3.02M | $ -2.92M | $ 0 | -0.28% |
3/31/2024 | $ 62.73M | $ 3.07M | $ -3.21M | $ 0 | 0.22% |
12/31/2023 | $ 86.82M | $ 31.42M | $ -1.33M | $ 0 | -34.66% |
9/30/2023 | $ 106.74M | $ 30.73M | $ -742K | $ 0 | -28.1% |
6/30/2023 | $ 238.89M | $ 30.69M | $ 719K | $ 0 | -13.15% |
3/31/2023 | $ 227.44M | $ 30.64M | $ 941K | $ 0 | -13.89% |
We picked the following companies as peers based on multiple factors, including sector, industry, market capitalization and revenue
(-1 * CF - Equity -1 * CF - Dividends -1 * CF - Debt) / Market Cap
(=) Shareholder Yield
Shareholder Yield for CARISMA THERAPEUTICS INC is calculated as follows: (-1 * CF - Equity [ $ 20.24M ] -1 * CF - Dividends [ $ 0 ] -1 * CF - Debt [ $ 0 ]) / Market Cap [ $ 143.57M ]
(=) Shareholder Yield [ -14.1% ]
Minimum
Dec 31, 2021
Maximum
Mar 31, 2025
Average
Median
filtered constituents | 3.48K |
---|---|
min | -33.43% |
max | 34.45% |
average | 0.58% |
median | 1.07% |
std | 11.12% |